logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5209.produswest2
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5209.produswest2
Showing 1 - 3 of 3 Items
Showing 1 - 3 of 3 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Commentary

Ten priorities for expanding access to HCV treatment for people who inject drugs in low- and middle-income countries

Ford NP, Wiktor SZ, Kaplan K, Andrieux-Meyer I, Hill AM,  et al.
2015-05-18 • International Journal of Drug Policy
2015-05-18 • International Journal of Drug Policy
Journal Article
|
Research

Prevalence of HIV, viral hepatitis B/C and tuberculosis and treatment outcomes among people who use drugs: Results from the implementation of the first drop-in-center in Mozambique

Sema Baltazar C, Kellogg TA, Boothe M, Loarec A, de Abreu E,  et al.
2021-04-01 • International Journal of Drug Policy
2021-04-01 • International Journal of Drug Policy
BACKGROUND
People who use drugs (PWUD) which includes both people who inject drugs (PWID) and non-injection drug users (NIDU) are marginalized, experience high levels of stigma and d...
Journal Article
|
Short Report

Research Priorities to Achieve Universal Access to Hepatitis C Prevention, Management and Direct-Acting Antiviral Treatment Among People Who Inject Drugs

Grebely J, Bruneau J, Lazarus JV, Dalgard O, Bruggmann P,  et al.
2017-07-03 • International Journal of Drug Policy
2017-07-03 • International Journal of Drug Policy
Globally, it is estimated that 71.1 million people have chronic hepatitis C virus (HCV) infection, including an estimated 7.5 million people who have recently injected drugs (PWID). Ther...